Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Institutional Ownership: 1.06% (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603811 Zhejiang Cheng Yi Pharmaceutical Co Ltd SHSE:603811
85 GF Score
Price ¥7.01
GF Value ¥7.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Zhejiang Cheng Yi Pharmaceutical Co Institutional Ownership?

Zhejiang Cheng Yi Pharmaceutical Co SHSE:603811 -0.14% 85 Institutional Ownership is 1.06% as of Sep. 22, 2026. GuruFocus rates SHSE:603811 with a GF Score™ of 85/100 and a GF Value™ of ¥7.73 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zhejiang Cheng Yi Pharmaceutical Co's institutional ownership is 1.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zhejiang Cheng Yi Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zhejiang Cheng Yi Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Zhejiang Cheng Yi Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Cheng Yi Pharmaceutical Co Institutional Ownership Chart

Zhejiang Cheng Yi Pharmaceutical Co Historical Data

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 2.71 0.56 0.56 0.56 0.56 0.55 0.55 1.06 1.06 1.06
SHSE:603811
85GF Score
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHSE:603811
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Cheng Yi Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.06% mean?
Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) has a Institutional Ownership of 1.06% as of Sep. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors.
Is Zhejiang Cheng Yi Pharmaceutical Co's Institutional Ownership too high?
Zhejiang Cheng Yi Pharmaceutical Co's current Institutional Ownership is 1.06%. Overall, Zhejiang Cheng Yi Pharmaceutical Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Cheng Yi Pharmaceutical Co's Institutional Ownership compare to ZTS?
Zhejiang Cheng Yi Pharmaceutical Co's Institutional Ownership of 1.06% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors. Zhejiang Cheng Yi Pharmaceutical Co's current Institutional Ownership is 1.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Cheng Yi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.73, compared to a current price of ¥7.01 — trading 9.3% below its estimated fair value. The current Institutional Ownership is 1.06%. Zhejiang Cheng Yi Pharmaceutical Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811), the current Institutional Ownership is 1.06% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.01 is trading 9.3% below its estimated GF Value™ of ¥7.73. GuruFocus considers Zhejiang Cheng Yi Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603811:

  • Institutional Ownership: 1.06%
  • GF Value™: ¥7.73 vs. price of ¥7.01 (9.3% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603811 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Cheng Yi Pharmaceutical Co Business Description

Address Lane 988, Shenhong Road, 7th Floor, No. 9, Building 20, Fuli Yuedu, Minhang District, Shanghai, CHN, 201100
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
85GF Score

Get the complete analysis for SHSE:603811

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.01
Price
¥7.73
GF Value